Panacos Pharmaceuticals is a biopharmaceutical company with a strategic focus on the discovery and development of novel antiviral drugs and vaccines.The Company's lead compounds are PA-344B and PA-457, potent HIV inhibitors with novel mechanisms of action compared with approved drugs. These compounds are currently in pre-clinical development and Panacos plans to file an IND to initiate human clinical testing in 2002.
